ABBV vs GILD
AbbVie vs Gilead Sciences — AI-powered side-by-side comparison
| Metric | ABBV | GILD |
|---|---|---|
| AI Score | 52 | 63 |
| Price | $254.38 | $136.28 |
| P/E Ratio | 119.75× | 18.11× |
| ROE | -1.3% | 42.2% |
| Revenue Growth YoY | — | 3.5% |
| Gross Margin | 0.7% | 79.3% |
| Debt / Equity | 2.65× | 1.10× |
| Dividend Yield | 0.0% | 2.4% |
| RSI (14) | 44.6 | 54.5 |
| Beta | 0.283 | 0.3411 |
| Expected Upside | +0.2% | +19.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABBV Full Analysis
GILD Full Analysis